Insider Trading activities of Momenta Pharmaceuticals Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MNTA. The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $75,395,716.
The total value of stock option exercises since 2005 is $11,001,864.



Table 2. Detailed insider stock purchases, sales, and option exercises of Momenta Pharmaceuticals Inc insiders (MNTA) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-05-23 Leicher Bruce (SVP & General Counsel) Sale 189 13.90 2,627
2012-05-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 240 13.90 3,336
2012-05-23 Shea Richard P (SVP, CFO) Sale 189 13.90 2,627
2012-05-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 208 13.90 2,891
2012-05-23 Wheeler Craig A (President) Sale 2,109 13.98 29,483
2012-05-22 Leicher Bruce (SVP & General Counsel) Sale 501 14.38 7,204
2012-05-21 Roach James M. (Senior VP, Development and Chi) Sale 192 13.87 2,663
2012-05-21 Leicher Bruce (SVP & General Counsel) Sale 192 13.87 2,663
2012-05-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 243 13.87 3,370
2012-05-21 Shea Richard P (SVP, CFO) Sale 192 13.87 2,663
2012-05-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 13.87 2,926
2012-05-21 Wheeler Craig A (President) Sale 2,110 14.15 29,856
2012-05-10 Shapiro Bennett M Sale 2,000 13.94 27,880
2012-04-19 Roach James M. (Senior VP, Development and Chi) Sale 15,000 15.10 226,500
2012-04-10 Shapiro Bennett M Sale 2,000 15.39 30,780
2012-03-12 Shapiro Bennett M Sale 2,000 15.03 30,060
2012-02-28 Roach James M. (Senior VP, Development and Chi) Sale 191 14.90 2,845
2012-02-28 Leicher Bruce (SVP & General Counsel) Sale 135 14.90 2,011
2012-02-28 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 284 14.90 4,231
2012-02-28 Shea Richard P (SVP, CFO) Sale 173 14.90 2,577
2012-02-28 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 182 14.90 2,711
2012-02-28 Wheeler Craig A (President) Sale 2,109 15.00 31,635
2012-02-24 Roach James M. (Senior VP, Development and Chi) Sale 708 15.71 11,122
2012-02-24 Leicher Bruce (SVP & General Counsel) Sale 708 15.71 11,122
2012-02-24 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 1,103 15.71 17,328
2012-02-24 Shea Richard P (SVP, CFO) Sale 708 15.71 11,122
2012-02-24 Venkataraman Ganesh (Senior V.P., Research) Sale 779 15.71 12,238
2012-02-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 307 15.16 4,654
2012-02-23 Shea Richard P (SVP, CFO) Sale 218 15.16 3,304
2012-02-23 Venkataraman Ganesh (Senior V.P., Research) Sale 102 15.16 1,546
2012-02-23 Wheeler Craig A (President) Sale 10,548 15.45 162,966
2012-02-22 Roach James M. (Senior VP, Development and Chi) Sale 191 15.11 2,886
2012-02-22 Leicher Bruce (SVP & General Counsel) Sale 692 15.11 10,456
2012-02-22 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 297 15.11 4,487
2012-02-22 Shea Richard P (SVP, CFO) Sale 191 15.11 2,886
2012-02-22 Venkataraman Ganesh (Senior V.P., Research) Sale 211 15.11 3,188
2012-02-22 Wheeler Craig A (President) Sale 2,109 15.07 31,782
2012-02-10 Shapiro Bennett M Sale 2,000 15.41 30,820
2012-01-11 Shapiro Bennett M Sale 2,000 19.39 38,780
2011-12-19 Sulat James R Option Ex 3,000 14.09 42,270
2011-12-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 426 15.92 6,781
2011-12-12 Shapiro Bennett M Sale 2,000 15.41 30,820
2011-11-28 Roach James M. (Senior VP, Development and Chi) Sale 192 14.97 2,874
2011-11-28 Leicher Bruce (SVP & General Counsel) Sale 135 14.97 2,020
2011-11-28 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 284 14.97 4,251
2011-11-28 Shea Richard P (SVP, CFO) Sale 173 14.97 2,589
2011-11-28 Venkataraman Ganesh (Senior V.P., Research) Sale 182 14.97 2,724
2011-11-28 Wheeler Craig A (President) Sale 2,110 14.90 31,439
2011-11-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 309 14.97 4,625
2011-11-23 Shea Richard P (SVP, CFO) Sale 219 14.97 3,278
2011-11-23 Venkataraman Ganesh (Senior V.P., Research) Sale 103 14.97 1,541
2011-11-23 Wheeler Craig A (President) Sale 2,110 14.84 31,312
2011-11-22 Leicher Bruce (SVP & General Counsel) Sale 501 14.85 7,439
2011-11-22 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,498 14.88 37,170
2011-11-21 Roach James M. (Senior VP, Development and Chi) Sale 193 15.01 2,896
2011-11-21 Leicher Bruce (SVP & General Counsel) Sale 193 15.01 2,896
2011-11-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 299 15.01 4,487
2011-11-21 Shea Richard P (SVP, CFO) Sale 193 15.01 2,896
2011-11-21 Venkataraman Ganesh (Senior V.P., Research) Sale 212 15.01 3,182
2011-11-21 Wheeler Craig A (President) Sale 2,110 14.87 31,375
2011-11-10 Shapiro Bennett M Sale 2,000 14.63 29,260
2011-10-11 Shapiro Bennett M Sale 2,000 12.33 24,660
2011-09-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 426 17.38 7,403
2011-09-12 Shapiro Bennett M Sale 2,000 16.10 32,200
2011-09-01 Stoner Elizabeth Sale 1,320 16.94 22,360
2011-08-26 Roach James M. (Senior VP, Development and Chi) Sale 193 16.07 3,101
2011-08-26 Leicher Bruce (SVP & General Counsel) Sale 136 16.07 2,185
2011-08-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 286 16.08 4,598
2011-08-26 Shea Richard P (SVP, CFO) Sale 174 16.07 2,796
2011-08-26 Venkataraman Ganesh (Senior V.P., Research) Sale 183 16.07 2,940
2011-08-26 Wheeler Craig A (President) Sale 2,109 16.28 34,334
2011-08-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,805 16.21 45,460
2011-08-23 Shea Richard P (SVP, CFO) Sale 218 15.58 3,396
2011-08-23 Venkataraman Ganesh (Senior V.P., Research) Sale 102 15.58 1,589
2011-08-23 Wheeler Craig A (President) Sale 2,109 15.50 32,689
2011-08-22 Leicher Bruce (SVP & General Counsel) Sale 500 16.62 8,310
2011-08-19 Roach James M. (Senior VP, Development and Chi) Sale 194 15.67 3,039
2011-08-19 Leicher Bruce (SVP & General Counsel) Sale 194 15.67 3,039
2011-08-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 302 15.67 4,732
2011-08-19 Shea Richard P (SVP, CFO) Sale 194 15.67 3,039
2011-08-19 Venkataraman Ganesh (Senior V.P., Research) Sale 213 15.67 3,337
2011-08-19 Wheeler Craig A (President) Sale 2,109 15.97 33,680
2011-08-16 Shea Richard P (SVP, CFO) Sale 304 17.11 5,201
2011-08-10 Shapiro Bennett M Sale 800 16.07 12,856
2011-07-11 Shapiro Bennett M Sale 1,200 20.53 24,636
2011-07-07 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 4,987 20.92 104,328
2011-07-05 Venkataraman Ganesh (Senior V.P., Research) Sale 15,900 20.35 323,565
2011-07-05 Wheeler Craig A (President) Sale 6,700 20.15 135,005
2011-06-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 429 18.17 7,794
2011-06-10 Shapiro Bennett M Sale 2,000 19.03 38,060
2011-06-08 Venkataraman Ganesh (Senior V.P., Research) Sale 9,100 20.36 185,276
2011-06-08 Wheeler Craig A (President) Sale 14,200 20.20 286,840
2011-06-01 Stoner Elizabeth Sale 900 20.11 18,099
2011-05-31 Wheeler Craig A (President) Sale 12,100 20.16 243,936
2011-05-26 Roach James M. (Senior VP, Development and Chi) Sale 191 19.20 3,667
2011-05-26 Leicher Bruce (SVP & General Counsel) Sale 135 19.20 2,592
2011-05-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 284 19.20 5,452
2011-05-26 Shea Richard P (SVP, CFO) Sale 172 19.20 3,302
2011-05-26 Venkataraman Ganesh (Senior V.P., Research) Sale 182 19.20 3,494
2011-05-26 Wheeler Craig A (President) Sale 2,110 19.20 40,512
2011-05-24 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 307 18.69 5,737
2011-05-24 Shea Richard P (SVP, CFO) Sale 217 18.69 4,055
2011-05-24 Venkataraman Ganesh (Senior V.P., Research) Sale 102 18.69 1,906
2011-05-24 Wheeler Craig A (President) Sale 2,110 18.69 39,435
2011-05-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,498 18.27 45,638
2011-05-20 Roach James M. (Senior VP, Development and Chi) Sale 388 18.55 7,196
2011-05-20 Leicher Bruce (SVP & General Counsel) Sale 1,390 18.55 25,784
2011-05-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 602 18.55 11,166
2011-05-20 Shea Richard P (SVP, CFO) Sale 388 18.55 7,196
2011-05-20 Venkataraman Ganesh (Senior V.P., Research) Sale 426 18.55 7,902
2011-05-19 Wheeler Craig A (President) Sale 4,218 18.42 77,694
2011-05-17 Shea Richard P (SVP, CFO) Sale 301 18.78 5,652
2011-05-10 Shapiro Bennett M Sale 2,000 19.19 38,380
2011-04-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 7,034 18.86 132,661
2011-04-11 Shapiro Bennett M Sale 2,000 15.29 30,580
2011-03-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,497 14.88 37,155
2011-03-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 436 13.94 6,077
2011-03-10 Shapiro Bennett M Sale 2,000 13.99 27,980
2011-03-01 Stoner Elizabeth Sale 1,560 13.50 21,060
2011-02-28 Roach James M. (Senior VP, Development and Chi) Sale 192 13.85 2,659
2011-02-28 Leicher Bruce (SVP & General Counsel) Sale 135 13.85 1,869
2011-02-28 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 284 13.85 3,933
2011-02-28 Shea Richard P (SVP, CFO) Sale 173 13.85 2,396
2011-02-28 Venkataraman Ganesh (Senior V.P., Research) Sale 182 13.85 2,520
2011-02-28 Wheeler Craig A (President) Sale 2,109 13.82 29,146
2011-02-23 Leicher Bruce (SVP & General Counsel) Sale 501 13.26 6,643
2011-02-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 308 13.26 4,084
2011-02-23 Shea Richard P (SVP, CFO) Sale 218 13.26 2,890
2011-02-23 Venkataraman Ganesh (Senior V.P., Research) Sale 102 13.26 1,352
2011-02-23 Wheeler Craig A (President) Sale 2,109 13.28 28,007
2011-02-22 Roach James M. (Senior VP, Development and Chi) Sale 761 13.45 10,235
2011-02-22 Leicher Bruce (SVP & General Counsel) Sale 761 13.45 10,235
2011-02-22 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 1,185 13.45 15,938
2011-02-22 Shea Richard P (SVP, CFO) Sale 761 13.45 10,235
2011-02-22 Venkataraman Ganesh (Senior V.P., Research) Sale 837 13.45 11,257
2011-02-22 Wheeler Craig A (President) Sale 8,437 13.38 112,887
2011-02-16 Stoner Elizabeth Sale 6,000 13.55 81,300
2011-02-16 Shea Richard P (SVP, CFO) Sale 301 13.62 4,099
2011-02-15 Stoner Elizabeth Sale 2,340 13.01 30,443
2011-02-14 Sulat James R Option Ex 7,000 12.34 86,380
2010-12-16 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 426 14.83 6,317
2010-12-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 426 14.42 6,142
2010-12-14 Hutt Peter Barton Sale 64,000 14.35 918,400
2010-12-14 Hutt Peter Barton Option Ex 64,000 .23 14,784
2010-12-10 Hutt Peter Barton Sale 62,498 14.67 916,845
2010-11-29 Roach James M. (Senior VP, Development and Chi) Sale 192 15.22 2,922
2010-11-29 Leicher Bruce (SVP & General Counsel) Sale 135 15.22 2,054
2010-11-29 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 285 15.22 4,337
2010-11-29 Shea Richard P (SVP, CFO) Sale 173 15.22 2,633
2010-11-29 Venkataraman Ganesh (Senior V.P., Research) Sale 182 15.22 2,770

Insider trading activities including stock purchases, stock sales, and option exercises of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA, CIK number 1235010) see the Securities and Exchange Commission (SEC) website.